BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19138973)

  • 1. (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice.
    Shimizu M; Shirakami Y; Sakai H; Adachi S; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Prev Res (Phila); 2008 Sep; 1(4):298-304. PubMed ID: 19138973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
    Shimizu M; Shirakami Y; Iwasa J; Shiraki M; Yasuda Y; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
    Clin Cancer Res; 2009 May; 15(9):3068-75. PubMed ID: 19366832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db Mice.
    Shimizu M; Sakai H; Shirakami Y; Yasuda Y; Kubota M; Terakura D; Baba A; Ohno T; Hara Y; Tanaka T; Moriwaki H
    Cancer Prev Res (Phila); 2011 Mar; 4(3):396-403. PubMed ID: 21372039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.
    Hirose Y; Hata K; Kuno T; Yoshida K; Sakata K; Yamada Y; Tanaka T; Reddy BS; Mori H
    Carcinogenesis; 2004 May; 25(5):821-5. PubMed ID: 14729596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
    Yasuda Y; Shimizu M; Shirakami Y; Sakai H; Kubota M; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Sci; 2010 Jul; 101(7):1701-7. PubMed ID: 20398056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive effects of curcumin on the development of azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db obese mice.
    Kubota M; Shimizu M; Sakai H; Yasuda Y; Terakura D; Baba A; Ohno T; Tsurumi H; Tanaka T; Moriwaki H
    Nutr Cancer; 2012; 64(1):72-9. PubMed ID: 22172229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
    Miyamoto S; Yasui Y; Ohigashi H; Tanaka T; Murakami A
    Chem Biol Interact; 2010 Jan; 183(2):276-83. PubMed ID: 19914226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
    Kubota M; Shimizu M; Sakai H; Yasuda Y; Ohno T; Kochi T; Tsurumi H; Tanaka T; Moriwaki H
    Biochem Biophys Res Commun; 2011 Jun; 410(1):108-13. PubMed ID: 21640075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
    Shimizu M; Deguchi A; Hara Y; Moriwaki H; Weinstein IB
    Biochem Biophys Res Commun; 2005 Sep; 334(3):947-53. PubMed ID: 16053920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of astaxanthin on azoxymethane-induced colonic preneoplastic lesions in C57/BL/KsJ-db/db mice.
    Kochi T; Shimizu M; Sumi T; Kubota M; Shirakami Y; Tanaka T; Moriwaki H
    BMC Gastroenterol; 2014 Dec; 14():212. PubMed ID: 25515685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats.
    Suzuki R; Yasui Y; Kohno H; Miyamoto S; Hosokawa M; Miyashita K; Tanaka T
    Oncol Rep; 2006 Nov; 16(5):989-96. PubMed ID: 17016582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells.
    Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Kubota M; Adachi S; Tsurumi H; Hara Y; Moriwaki H
    Chem Biol Interact; 2010 May; 185(3):247-52. PubMed ID: 20346928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
    Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrus auraptene suppresses azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db mice.
    Hayashi K; Suzuki R; Miyamoto S; Shin-Ichiroh Y; Kohno H; Sugie S; Takashima S; Tanaka T
    Nutr Cancer; 2007; 58(1):75-84. PubMed ID: 17571970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice.
    Iwasa J; Shimizu M; Shiraki M; Shirakami Y; Sakai H; Terakura Y; Takai K; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Sci; 2010 Feb; 101(2):460-7. PubMed ID: 19906067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats.
    Raju J; Bird RP
    Cancer Res; 2003 Oct; 63(20):6595-601. PubMed ID: 14583451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet supplemented with citrus unshiu segment membrane suppresses chemically induced colonic preneoplastic lesions and fatty liver in male db/db mice.
    Suzuki R; Kohno H; Yasui Y; Hata K; Sugie S; Miyamoto S; Sugawara K; Sumida T; Hirose Y; Tanaka T
    Int J Cancer; 2007 Jan; 120(2):252-8. PubMed ID: 17066427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.
    Saxena A; Shoeb M; Tammali R; Ramana KV; Srivastava SK
    Cancer Lett; 2014 Dec; 355(1):141-7. PubMed ID: 25218594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
    Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
    Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R.
    Yasuda Y; Shimizu M; Sakai H; Iwasa J; Kubota M; Adachi S; Osawa Y; Tsurumi H; Hara Y; Moriwaki H
    Chem Biol Interact; 2009 Dec; 182(2-3):159-64. PubMed ID: 19646978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.